K
Kenota (formerly ExVivo Labs)
Develops next generation medical diagnostic tools
About Kenota (formerly ExVivo Labs)
Kenota is a pioneering company in the healthcare sector, specifically focusing on allergy testing. The company has developed an innovative system that allows for lab-quality IgE allergy testing directly within clinics. This enables healthcare providers to quickly and accurately diagnose allergies in a single visit, enhancing the patient-physician connection. Kenota's primary clients are allergy professionals and clinics that seek to improve their diagnostic capabilities. Operating in the medical diagnostics market, Kenota's business model revolves around providing advanced testing tools and technology to healthcare providers. The company generates revenue through the sale of its testing systems and related services. Kenota has been actively engaged with regulatory bodies like the FDA to ensure the safety, effectiveness, and compliance of its products. The company is led by experienced professionals with extensive backgrounds in laboratory and regulated businesses.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Kitchener, Canada
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 58.2/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Allergy, Health Diagnostics, Hard Tech, YC S16, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2020 | $9M | $36M | Y Combinator · BoxOne Ventures · Draper Associates · BDC Capital | ↗ |
| OtherOther financing | Dec 2018 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Kenota (formerly ExVivo Labs) is 1.8K monthly website visits, up 20% over the last three months. Kenota (formerly ExVivo Labs)'s team declined 73.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A12 investors entered at this stage
OS Fund
Pegasus Tech Ventures
Hedgewood
Fifty Years
1517 Fund
KBW Ventures
Advisors.Fund
Upslope Ventures
Draper Associates
BoxOne Ventures
BDC Capital- CTCollin Terpstra
Other known investors5 additional known investors
Cur8 Capital
MetaPlanet
Nucleate
Saltagen Ventures
Velocity
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kenota (formerly ExVivo Labs) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kenota (formerly ExVivo Labs)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.